New grad roles at Parabilis Medicines
Parabilis Medicines is a public, clinical-stage biopharmaceutical company developing Helicon peptide medicines for historically undruggable protein targets. Its pipeline focuses on oncology and other serious diseases, including the lead investigational medicine zolucatetide.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Series D
- Open roles
- 11
Get new Parabilis Medicines new grad roles by email
Free account. Get new Parabilis Medicines new grad roles by email or push the minute they post.
